TITLE

Reports of “Satisfactory Relief” by IBS Patients Receiving Usual Medical Care Are Confounded by Baseline Symptom Severity and Do Not Accurately Reflect Symptom Improvement

AUTHOR(S)
Whitehead, William E.; Palsson, Olafur S.; Levy, Rona L.; Feld, Andrew D.; VonKorff, Michael; Turner, Marsha
PUB. DATE
May 2006
SOURCE
American Journal of Gastroenterology;May2006, Vol. 101 Issue 5, p1057
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Treatment trials for irritable bowel syndrome (IBS) usually define a responder as a patient who reports satisfactory relief or adequate relief of symptoms at the end of the trial. However, these measures have not been adequately validated. AIMS: (1) Compare a binary satisfactory relief measure to alternative ways of defining a treatment responder. (2) Determine whether baseline IBS symptom severity or psychological distress influence the sensitivity of these outcome measures. METHODS: A total of 350 patients (81% females, average age 50 yr) who had a medical diagnosis of IBS and satisfied Rome II criteria, were recruited from Group Health Cooperative of Puget Sound. At baseline the Irritable Bowel Severity Scale (IBSS) was used to assess symptom severity and to classify patients as mild, moderate, or severe. Psychological distress and IBS-specific quality of life (IBS-QOL) were also assessed. After 6 months treatment with standard medical care, IBSS and IBS-QOL were reassessed, and patients were asked whether they had experienced satisfactory relief and whether they were somewhat or markedly better. RESULTS: Initial severity of IBS significantly affected the proportion who reported satisfactory relief (mild, 72%; moderate, 53%; severe, 44%) and the proportion who were somewhat or markedly better (mild, 62%; moderate, 44%; severe, 38%), but did not affect the proportion with a 50% reduction in symptoms (mild, 26%; moderate, 25%; severe, 23%). Although mild patients were the most likely to report satisfactory relief, they showed no average decrease in symptom severity or improvement in IBS-QOL. Conversely, severe patients, who were the least likely to report satisfactory relief, had the largest reductions in IBS symptom severity and the largest improvements in IBS-QOL. Psychological distress had no significant effect on the responder rate after adjusting for IBS symptom severity. CONCLUSIONS: These data from a descriptive study suggest that satisfactory relief is confounded with initial IBS symptom severity and is poorly correlated with the amount of symptom improvement. Confirmation of these findings in a clinical trial is needed.
ACCESSION #
20785735

 

Related Articles

  • While poorly understood, IBS is uniquely suited to DM intervention. Reese, Shelly // Managed Healthcare Executive;Aug2004, Vol. 14 Issue 8, p42 

    Focuses on the health care delivery for irritable bowel syndrome (IBS). Difficulty in diagnosing and managing IBS; Characterization of abdominal discomfort and altered bowel habits; Inclusion of therapy such as fiber therapy, food elimination and stress management.

  • Managing irritable bowel syndrome. Horwitz, Brenda L.; Lembo, Anthony J.; Whitehead, William E. // Patient Care;Feb2003, Vol. 37 Issue 2, p18 

    Presents information on irritable bowel syndrome (IBS). Description and symptoms of IBS; Information on foods that can trigger IBS; Risk factors of IBS. INSET: The therapeutic relationship in IBS.

  • Rationale for using serotonergic agents to treat irritable bowel syndrome. Baker, Danial E. // American Journal of Health-System Pharmacy;4/1/2005, Vol. 62 Issue 7, p700 

    Purpose. The role of serotonin in gastrointestinal (GI)-tract functioning, the pharmacologic rationale for using serotonergic agents in the treatment of irritable bowel syndrome (IBS), and clinical experience with novel serotonergic agents are described. Summary. IBS is a common multisymptom...

  • Rationale for using serotonergic agents to treat irritable bowel syndrome.  // American Journal of Health-System Pharmacy;4/1/2005, Vol. 62 Issue 7, p712 

    Focuses on the rationale for using serotonergic agents to treat irritable bowel syndrome. Identification of learning objectives; Self-assessment questions; Scoring methods of the tests.

  • Role of Tumor Necrosis Factor-α and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome. van der Veek, Patrick P. J.; van den Berg, Marlies; de Kroon, Yvette E.; Verspaget, Hein W.; Masclee, Ad A. M. // American Journal of Gastroenterology;Nov2005, Vol. 100 Issue 11, p2510 

    OBJECTIVES: Imbalances in the genetically controlled pro- and anti-inflammatory cytokine production may promote ongoing low-grade inflammation after an acute gastroenteritis, and subsequently, irritable bowel syndrome (IBS) (post-infectious IBS, PI-IBS). We studied gene promoter single...

  • Occurrence of Colon Ischemia in Relation to Irritable Bowel Syndrome. Cole, J. Alexander; Cook, Suzanne F.; Sands, Bruce E.; Ajene, Anuli N.; Miller, David P.; Walker, Alexander M. // American Journal of Gastroenterology;Mar2004, Vol. 99 Issue 3, p486 

    OBJECTIVE: In November 2000, alosetron HCl (Lotronex®), a treatment for irritable bowel syndrome (IBS), was removed from the U.S. market in part because of the occurrence of colon ischemia in treated patients. Since the relation between colon ischemia and IBS is poorly understood, we...

  • Irritable Bowel Syndrome in Persons Who Acquired Trichinellosis. Soyturk, Mujde; Akpinar, Hale; Gurler, Oguz; Pozio, Edoardo; Sari, Ismail; Akar, Servet; Akarsu, Mesut; Birlik, Merih; Onen, Fatos; Akkoc, Nurullah // American Journal of Gastroenterology;May2007, Vol. 102 Issue 5, p1064 

    BACKGROUND AND AIM: The postinfectious irritable bowel syndrome (PI-IBS) frequently follows bacterial infections. Since people suffering from PI-IBS and Trichinella spiralis–infected mice develop similar findings, this animal model has been successfully used for PI-IBS studies; however,...

  • The Radiology Corner. Messinger, Neil H.; Beneventano, Thomas C. // American Journal of Gastroenterology;Aug1971, Vol. 56 Issue 2, p162 

    Discusses ischemic colonic disease associated with carcinoma of the colon. Radiologic features of the disease; Pictures of the disease.

  • Accelerated Right Colonic Emptying After Simulated Upper Gut Hemorrhage. Hammer, Johann; Lang, Karin; Kletter, Kurt // American Journal of Gastroenterology;Apr1998, Vol. 93 Issue 4, p628 

    Objective: Upper gastrointestinal hemorrhage delays gastric emptying. Our aim was to evaluate the effect of gastrointestinal hemorrhage on small intestinal, ileocecal, and proximal colonic transit. Methods: Healthy volunteers were randomized to receive either a duodenal infusion of heparinized...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics